• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝 LKB1 通过基因组雄激素受体信号通路减少非酒精性脂肪性肝病的进展。

Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling.

机构信息

Department of Veterinary Biochemistry, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea.

Department of Veterinary Toxicology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea.

出版信息

Int J Mol Sci. 2021 Jul 23;22(15):7904. doi: 10.3390/ijms22157904.

DOI:10.3390/ijms22157904
PMID:34360667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8348493/
Abstract

The incidence of non-alcoholic fatty liver disease (NAFLD) increases in males aged >45 years, which indicates that androgens are associated with the development and/or progression of NAFLD, although excess dietary intake is the primary causative factor. However, it is uncertain how androgens are involved in the metabolic process of NAFLD, which is associated with the state of steatosis in hepatocytes. To investigate whether androgen receptor (AR) signaling influences NAFLD development, the state of steatosis was monitored in mouse livers and hepatocytes with or without androgens. As a result, hepatic lipid droplets, expression of AR, and phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) increased in the presence of testosterone. Concurrently, the expression of LKB1, an upstream regulator of AMPK, was increased by testosterone treatment. We observed that the fluctuation of AMPK-ACC signaling, which plays an important role in lipogenesis, depends on the presence of testosterone and AR. Additionally, we demonstrated that testosterone bound AR was recruited to the promoter of the gene and induced LKB1 expression. Our study highlights a novel mechanism by which testosterone modulates NAFLD development by inducing the mRNA expression of .

摘要

非酒精性脂肪性肝病(NAFLD)的发病率在 >45 岁的男性中增加,这表明雄激素与 NAFLD 的发生和/或进展有关,尽管过量的饮食摄入是主要的致病因素。然而,雄激素如何参与 NAFLD 的代谢过程尚不清楚,这与肝细胞脂肪变性的状态有关。为了研究雄激素受体(AR)信号是否影响 NAFLD 的发生,在有或没有雄激素的情况下监测了小鼠肝脏和肝细胞中的脂肪变性状态。结果表明,在睾酮存在的情况下,肝内脂质滴、AR 的表达以及 AMP 激活的蛋白激酶(AMPK)和乙酰辅酶 A 羧化酶(ACC)的磷酸化增加。同时,LKB1 的表达,一种 AMPK 的上游调节剂,也被睾酮处理所增加。我们观察到,在脂肪生成中起重要作用的 AMPK-ACC 信号的波动取决于睾酮和 AR 的存在。此外,我们证明,与 AR 结合的睾酮被募集到 基因的启动子上,并诱导 LKB1 的表达。我们的研究强调了一种新的机制,即睾酮通过诱导 基因的 mRNA 表达来调节 NAFLD 的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/16efe6b2ea75/ijms-22-07904-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/0b7b95342bd4/ijms-22-07904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/de828df7fb28/ijms-22-07904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/26ff5b14fcbe/ijms-22-07904-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/a5a9ca7aadee/ijms-22-07904-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/f99252bb034f/ijms-22-07904-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/16efe6b2ea75/ijms-22-07904-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/0b7b95342bd4/ijms-22-07904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/de828df7fb28/ijms-22-07904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/26ff5b14fcbe/ijms-22-07904-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/a5a9ca7aadee/ijms-22-07904-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/f99252bb034f/ijms-22-07904-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d33/8348493/16efe6b2ea75/ijms-22-07904-g006.jpg

相似文献

1
Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling.肝 LKB1 通过基因组雄激素受体信号通路减少非酒精性脂肪性肝病的进展。
Int J Mol Sci. 2021 Jul 23;22(15):7904. doi: 10.3390/ijms22157904.
2
Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene.丁酸钠通过刺激肝激酶 B1 和胰岛素诱导基因抑制肝脂肪变性。
Cell Mol Gastroenterol Hepatol. 2021;12(3):857-871. doi: 10.1016/j.jcmgh.2021.05.006. Epub 2021 May 11.
3
Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.厚朴酚激活LKB1-AMPK信号通路并减轻肝细胞中的脂质积累。
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):113-24. doi: 10.1016/j.taap.2015.02.020. Epub 2015 Feb 28.
4
Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.用反义寡核苷酸治疗沉默小鼠中的 STE20 型激酶 MST3 可改善饮食诱导的非酒精性脂肪性肝病。
FASEB J. 2021 May;35(5):e21567. doi: 10.1096/fj.202002671RR.
5
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.心肌营养素-1 通过激活 AMPK 的机制消除肥胖小鼠的肝脂肪变性。
J Hepatol. 2014 May;60(5):1017-25. doi: 10.1016/j.jhep.2013.12.012. Epub 2013 Dec 19.
6
Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats.小檗胺激活 SIRT1/LKB1/AMPK 信号通路减轻高脂饮食诱导的非酒精性脂肪肝病大鼠肝脂肪变性的发展。
Food Funct. 2021 Jan 21;12(2):892-909. doi: 10.1039/d0fo02501a. Epub 2021 Jan 7.
7
Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat.雌激素/雄激素对雄性大鼠非酒精性脂肪肝预防的差异作用。
J Lipid Res. 2013 Feb;54(2):345-57. doi: 10.1194/jlr.M028969. Epub 2012 Nov 21.
8
Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.靶向递送 Stk25 反义寡核苷酸至肝细胞可保护小鼠免受非酒精性脂肪性肝病的影响。
Cell Mol Gastroenterol Hepatol. 2019;7(3):597-618. doi: 10.1016/j.jcmgh.2018.12.004. Epub 2018 Dec 19.
9
6-Gingerol Ameliorates Hepatic Steatosis, Inflammation and Oxidative Stress in High-Fat Diet-Fed Mice through Activating LKB1/AMPK Signaling.6-姜酚通过激活 LKB1/AMPK 信号改善高脂饮食喂养小鼠的肝脂肪变性、炎症和氧化应激。
Int J Mol Sci. 2023 Mar 27;24(7):6285. doi: 10.3390/ijms24076285.
10
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.新型异喹啉生物碱(S)YS - 51通过抑制脂肪生成、炎症和凝血来减轻小鼠肥胖相关的非酒精性脂肪性肝病。
Eur J Pharmacol. 2016 Oct 5;788:200-209. doi: 10.1016/j.ejphar.2016.06.040. Epub 2016 Jun 23.

引用本文的文献

1
Research progress on AMPK in the pathogenesis and treatment of MASLD.AMPK在代谢相关脂肪性肝病发病机制及治疗中的研究进展
Front Immunol. 2025 Mar 11;16:1558041. doi: 10.3389/fimmu.2025.1558041. eCollection 2025.
2
Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling.脂联素通过 AMPK 信号通路调节脂质积累和炎症反应,从而促进非酒精性脂肪性肝病的发生。
Immun Inflamm Dis. 2023 Aug;11(8):e947. doi: 10.1002/iid3.947.
3
The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study.

本文引用的文献

1
Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.睾酮可增加性腺功能减退症合并 2 型糖尿病男性 AMP 激酶 α 的表达和磷酸化。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):1169-75. doi: 10.1210/clinem/dgz288.
2
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.TGF-β 在肝星状细胞激活和肝纤维化中的作用-2019 更新版。
Cells. 2019 Nov 11;8(11):1419. doi: 10.3390/cells8111419.
3
Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause.
2 型糖尿病男性患者总睾酮与非酒精性脂肪性肝炎和非酒精性脂肪性肝病纤维化进展的相关性:一项横断面研究。
Eur J Med Res. 2022 Dec 27;27(1):307. doi: 10.1186/s40001-022-00958-8.
4
Spatiotemporal Regulation of Circular RNA Expression during Liver Development of Chinese Indigenous Ningxiang Pigs.中国地方猪种宁乡猪肝脏发育过程中环状 RNA 表达的时空调控。
Genes (Basel). 2022 Apr 24;13(5):746. doi: 10.3390/genes13050746.
性激素结合球蛋白可抑制绝经后非酒精性脂肪性肝病引发的肝癌发生。
Carcinogenesis. 2019 Aug 22;40(8):1031-1041. doi: 10.1093/carcin/bgz107.
4
Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase.天然产物辣椒素与多西他赛联合使用,通过代谢调节因子AMP激活的蛋白激酶协同杀死人前列腺癌细胞。
Cancer Cell Int. 2019 Mar 8;19:54. doi: 10.1186/s12935-019-0769-2. eCollection 2019.
5
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.肥胖与非酒精性脂肪性肝病:从病理生理学到治疗学。
Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29.
6
Non-alcoholic fatty liver disease - A global public health perspective.非酒精性脂肪性肝病——全球公共卫生视角。
J Hepatol. 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9.
7
Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis.孕激素受体膜成分 1 的缺失通过诱导从头脂肪生成促进肝脂肪变性。
Sci Rep. 2018 Oct 24;8(1):15711. doi: 10.1038/s41598-018-34148-6.
8
AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo.AMPK 激活通过增加体内脂肪氧化减少肝脏脂质含量。
Int J Mol Sci. 2018 Sep 19;19(9):2826. doi: 10.3390/ijms19092826.
9
Mechanisms of NAFLD development and therapeutic strategies.非酒精性脂肪性肝病发病机制及治疗策略。
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
10
Steatosis and NASH in type 2 diabetes.2 型糖尿病中的脂肪变性和 NASH。
Biochimie. 2017 Dec;143:37-41. doi: 10.1016/j.biochi.2017.10.019. Epub 2017 Oct 31.